Experience of the Local Treatment of Warts and Pointed Candylomas

Abstract

The clinical effectiveness and safety of the application of medicine Solcoderm has been studied during the treatment of 108 patients with warts (65 with viral warts and 33 with plantar ones) and 63 patients with pointed genital and anogenital candylomas. Of these, 62,0 % of the patients lost warts after a single application of Solcoderm, 21,3 % - after a second application and 11,1 % - after a third one. In total, 102 of the 108 patients became convalescent, i.e. 94,4 %. All the screened patients with pointed candylomas became clinically convalescent: after a single application of Solcoderm - in 68,3 % of cases, after a second application - in 23,8 % and a third one - in 7,9 % of the patients.